Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Kassim Javaid has joined an interdisciplinary team embarking on a new 3-year project to advise on the best practice of Artificial Intelligence (AI) in healthcare to ensure it benefits everyone in the UK and Japan.

Horizontal portrait of Kassim Javid

Professor Jane Kaye, Director of The Centre for Health, Law, and Emerging Technologies (HeLEX) at the University of Oxford, in collaboration with Professor Beverley Yamamoto of Osaka University in Japan has convened the interdisciplinary team which includes researchers from social science, medicine, life science, and ethical and legal backgrounds.

The research will adopt a mixed-methods approach and aims to investigate effective strategies to support a platform for stakeholder engagement and involvement in the development and implementation of AI technologies in healthcare settings. Alongside the empirical research, the project will recruit a patient and public involvement panel to contribute to the project activities.

"With AI increasingly being used within the NHS and in future potential applications, it is critical that patients and the public are involved as we develop the governance and privacy issues around this new technology," said Kassim. "As a clinician who has implemented AI in the NHS setting, I will be contributing to the clinical aspects as well as supporting the patient co-development of the outputs."

The research will focus on:

  • What are the current and anticipated uses of AI technologies in treatment, diagnostic decision-making and precision medicine;
  • Understanding the issues that stakeholders perceive will influence the adoption and implementation of AI in healthcare;
  • Identifying the types of engagement mechanisms, safeguards and regulatory controls they would like to see in place; and
  • How to development a platform for engagement that can address issues of trust, responsibility, accountability and transparency, and influence normative practices in the implementation of AI technologies in healthcare.

The project is one of six which have been funded through UK Research and Innovation's (UKRI) Fund for International Collaboration (FIC) in a joint UK-Japan initiative. The Economic and Social Research Council (ESRC) and the Arts and Humanities Research Council (AHRC), both part of UKRI, contributed £2.4m via FIC, while the Japanese Science and Technology Agency (JST) contributed ¥180m.

 

 

Similar stories

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.

NDORMS academics named NIHR Senior Investigators

Main

Congratulations to Professor Jonathan Rees who has been announced as a National Institute of Health Research (NIHR Senior Investigator).